Back to Journals » Breast Cancer: Targets and Therapy » Volume 3

Clinical utility of the combination of lapatinib and letrozole in the management of hormone receptor-positive and HER2-positive advanced breast cancer

Total article views   HTML views PDF downloads Totals
9,611 Dovepress* 9,054+ 2,222 11,276
PubMed Central* 557 184 741
Totals 9,611 2,406 12,017
*Since 26 October 2011
+Since July 2016

View citations on PubMed Central and Google Scholar